These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8624172)
21. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy. Hernández JA; Navarro JT; Force L Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328 [No Abstract] [Full Text] [Related]
22. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769 [No Abstract] [Full Text] [Related]
23. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Ritmeijer K; Veeken H; Melaku Y; Leal G; Amsalu R; Seaman J; Davidson RN Trans R Soc Trop Med Hyg; 2001; 95(6):668-72. PubMed ID: 11816442 [TBL] [Abstract][Full Text] [Related]
24. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Thakur CP; Sinha GP; Pandey AK; Kumar N; Kumar P; Hassan SM; Narain S; Roy RK Ann Trop Med Parasitol; 1998 Jul; 92(5):561-9. PubMed ID: 9797829 [TBL] [Abstract][Full Text] [Related]
25. Does antimony therapy cause bleeding in kala-azar patients and why? Chowdhury MA; Ahasan HA; Azhar MA; Rafiqueuddin AK; Islam MR; Misbahuddin M; Rashid MU Trop Doct; 1995 Oct; 25(4):188-9. PubMed ID: 7502336 [No Abstract] [Full Text] [Related]
27. Acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy. Sharma S; Malhan P; Pujani M; Rath B Indian J Pathol Microbiol; 2008; 51(4):546-7. PubMed ID: 19008592 [TBL] [Abstract][Full Text] [Related]
28. Sodium stibogluconate cardiotoxicity and safety of generics. Rijal S; Chappuis F; Singh R; Boelaert M; Loutan L; Koirala S Trans R Soc Trop Med Hyg; 2003; 97(5):597-8. PubMed ID: 15307436 [TBL] [Abstract][Full Text] [Related]
29. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan. Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033 [TBL] [Abstract][Full Text] [Related]
30. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India. Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981 [TBL] [Abstract][Full Text] [Related]
32. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. Donovan KL; White AD; Cooke DA; Fisher DJ J Infect; 1990 Jul; 21(1):107-10. PubMed ID: 2166765 [TBL] [Abstract][Full Text] [Related]
33. Case report: Acute renal injury as a result of liposomal amphotericin B treatment in sodium stibogluconate unresponsive visceral leishmaniasis. Zhao S; Zhang D; Li L; Mao Q Am J Trop Med Hyg; 2011 Dec; 85(6):1035-7. PubMed ID: 22144439 [TBL] [Abstract][Full Text] [Related]
34. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. Roberts WL; Hariprashad J; Rainey PM; Murray HW Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804 [TBL] [Abstract][Full Text] [Related]
35. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar. Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781 [TBL] [Abstract][Full Text] [Related]
36. [Pancreatic toxicity of antimonials in patients with infections]. Sánchez LA; Ferrero OL; Zubero Z; Teira R; Muñoz J; Baraia-Etxaburu J; Santamaría JM Rev Esp Enferm Dig; 2000 Nov; 92(11):765-6. PubMed ID: 11468860 [No Abstract] [Full Text] [Related]
37. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Sundar S; Sinha PR; Agrawal NK; Srivastava R; Rainey PM; Berman JD; Murray HW; Singh VP Am J Trop Med Hyg; 1998 Jul; 59(1):139-43. PubMed ID: 9684642 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerance of amphotericin B in a lipid emulsion in the treatment of visceral leishmaniasis in AIDS patients. Petit N; Parola P; Dhiver C; Gastaut JA J Antimicrob Chemother; 1996 Jul; 38(1):154-7. PubMed ID: 8858471 [No Abstract] [Full Text] [Related]
39. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia. Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362 [TBL] [Abstract][Full Text] [Related]
40. [Treatment of visceral leishmaniasis in children]. Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]